Literature DB >> 2409235

Calcium-stimulated proteolysis in myelin: evidence for a Ca2+-activated neutral proteinase associated with purified myelin of rat CNS.

N L Banik, W W McAlhaney, E L Hogan.   

Abstract

Incubation of myelin purified from rat spinal cord with CaCl2 (1-5 mM) in 10-50 mM Tris-HCl buffer at pH 7.6 containing 2 mM dithiothreitol resulted in the loss of both the large and small myelin basic proteins (MBPs), whereas incubation of myelin with Triton X-100 (0.25-0.5%) and 5 mM EGTA in the absence of calcium produced preferential extensive loss of proteolipid protein (PLP) relative to MBP. Inclusion of CaCl2 but not EGTA in the medium containing Triton X-100 enhanced degradation of both PLP and MBPs. The Ca2+-activated neutral proteinase (CANP) activity is inhibited by EGTA (5 mM) and partially inhibited by leupeptin and/or E-64c. CANP is active at pH 5.5-9.0, with the optimum at 7-8. The threshold of Ca2+ activation is approximately 100 microM. The 150K neurofilament protein (NFP) was progressively degraded when incubated with purified myelin in the presence of Ca2+. These results indicate that purified myelin is associated with and/or contains a CANP whose substrates include MBP, PLP, and 150K NFP. The degradation of PLP (trypsin-resistant) in the presence of detergent suggests either release of enzyme from membrane and/or structural alteration in the protein molecule rendering it accessible to proteolysis. The myelin-associated CANP may be important not only in the turnover of myelin proteins but also in myelin breakdown in brain diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409235     DOI: 10.1111/j.1471-4159.1985.tb04026.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  25 in total

Review 1.  The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.

Authors:  I A Scarisbrick
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

2.  Imaging Ca2+ changes in individual oligodendrocytes attacked by T-cell perforin.

Authors:  J Jones; S Frith; S Piddlesden; B P Morgan; D A Compston; A K Campbell; M B Hallett
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

3.  Degradation products of myelin-oligodendrocyte-associated proteins in a light CNS subcellular fraction.

Authors:  H Persson
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  The regional and subcellular distribution of calcium activated neutral proteinase (CANP) in the bovine central nervous system.

Authors:  A K Chakrabarti; N L Banik; J M Powers; E L Hogan
Journal:  Neurochem Res       Date:  1989-03       Impact factor: 3.996

Review 5.  Calmodulin-binding proteins as calpain substrates.

Authors:  K K Wang; A Villalobo; B D Roufogalis
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

6.  Ca-controlled, reversible structural transition in myelin.

Authors:  A E Blaurock; J L Yale; B I Roots
Journal:  Neurochem Res       Date:  1986-08       Impact factor: 3.996

7.  Oligodendrocyte susceptibility to injury by T-cell perforin.

Authors:  N J Scolding; J Jones; D A Compston; B P Morgan
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

8.  Inhibition of calpain attenuates encephalitogenicity of MBP-specific T cells.

Authors:  Mary K Guyton; Saurav Brahmachari; Arabinda Das; Supriti Samantaray; Jun Inoue; Mitsuyoshi Azuma; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

9.  Degradation of myelin basic protein by a membrane-associated metalloprotease: neural distribution of the enzyme.

Authors:  A Chantry; N Gregson; P Glynn
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

10.  Differential distribution of calpain in human lymphoid cells.

Authors:  R V Deshpande; J M Goust; N L Banik
Journal:  Neurochem Res       Date:  1993-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.